
Shares of healthcare giant Eli Lilly (LLY) have been on an absolute tear in the past decade. LLY is up 490% in the last five years and 1,450% in the last 10 years, after adjusting for dividends.
While many companies across numerous sectors are trading well below all-time highs after a broad-based pullback in markets, Eli Lilly touched a new record high this month, valuing the company at $577.46 billion by market cap.